{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T14:36:33Z","timestamp":1768833393910,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T00:00:00Z","timestamp":1414972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T00:00:00Z","timestamp":1414972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1038\/bmt.2014.244","type":"journal-article","created":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T15:57:48Z","timestamp":1415030268000},"page":"253-258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: A multicenter retrospective study from the Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Moelle et de Th\u00e9rapie Cellulaire (SFGM-TC)"],"prefix":"10.1038","volume":"50","author":[{"given":"M Y","family":"Detrait","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Morisset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Peffault de Latour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Yakoub-Agha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Crocchiolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-O","family":"Bay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Barraco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Raus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Vigouroux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Magro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Mohty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Milpied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Blaise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Soci\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Michallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,3]]},"reference":[{"key":"BFbmt2014244_CR1","doi-asserted-by":"publisher","first-page":"703","DOI":"10.7326\/0003-4819-87-6-703","volume":"87","author":"AA Gratwohl","year":"1977","unstructured":"Gratwohl AA, Moutsopoulos HM, Chused TM, Akizuki M, Wolf RO, Sweet JB et al. Sjogren-type syndrome after allogeneic bone-marrow transplantation. Ann Intern Med 1977; 87: 703\u2013706.","journal-title":"Ann Intern Med"},{"key":"BFbmt2014244_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bbmt.2005.10.023","volume":"12","author":"HM Shulman","year":"2006","unstructured":"Shulman HM, Kleiner D, Lee SJ, Morton T, Pavletic SZ, Farmer E et al. Histopathologic diagnosis of chronic graft-versus- host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant 2006; 12: 31\u201347.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014244_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0190-9622(92)70005-Z","volume":"26","author":"O Chosidow","year":"1992","unstructured":"Chosidow O, Bagot M, Vernant JP, Roujeau JC, Cordonnier C, Kuentz M et al. Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases. J Am Acad Dermatol 1992; 26: 49\u201355.","journal-title":"J Am Acad Dermatol"},{"key":"BFbmt2014244_CR4","first-page":"258","volume":"91","author":"C Skert","year":"2006","unstructured":"Skert C, Patriarca F, Sperotto A, Cerno M, Fili C, Zaja F et al. Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome. Haematologica 2006; 91: 258\u2013261.","journal-title":"Haematologica"},{"key":"BFbmt2014244_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.bbmt.2010.07.025","volume":"17","author":"Z Jedlickova","year":"2011","unstructured":"Jedlickova Z, Burlakova I, Bug G, Baurmann H, Schwerdtfeger R, Schleuning M . Therapy of sclerodermatous chronic graft-versus-host disease with mammalian target of rapamycin inhibitors. Biol Blood Marrow Transplant 2011; 17: 657\u2013663.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014244_CR6","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945\u2013956.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014244_CR7","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1182\/blood-2011-04-350249","volume":"118","author":"KJ Martires","year":"2011","unstructured":"Martires KJ, Baird K, Steinberg SM, Grkovic L, Joe GO, Williams KM et al. Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease. Blood 2011; 118: 4250\u20134257.","journal-title":"Blood"},{"key":"BFbmt2014244_CR8","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.1182\/blood-2012-10-464198","volume":"121","author":"Y Inamoto","year":"2013","unstructured":"Inamoto Y, Storer BE., Petersdorf EW., Nelson JL, Lee SJ, Carpenter PA et al. Incidence, risk factors and outcomes of sclerosis in patients with chronic graft-versus-host disease. Blood 2013; 121: 5098\u20135103.","journal-title":"Blood"},{"key":"BFbmt2014244_CR9","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1182\/blood-2010-08-302109","volume":"117","author":"ME Flowers","year":"2011","unstructured":"Flowers ME, Inamoto Y, Carpenter PA, Lee SJ, Kiem HP, Petersdorf EW et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 2011; 117: 3214\u20133219.","journal-title":"Blood"},{"key":"BFbmt2014244_CR10","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1182\/blood-2009-03-208983","volume":"114","author":"AC Vigorito","year":"2009","unstructured":"Vigorito AC, Campregher PV, Storer BE, Carpenter PA, Moravec CK, Kiem HP et al. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood 2009; 114: 702\u2013708.","journal-title":"Blood"},{"key":"BFbmt2014244_CR11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ . A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496\u2013509.","journal-title":"J Am Stat Assoc"},{"key":"BFbmt2014244_CR12","doi-asserted-by":"publisher","first-page":"6714","DOI":"10.1182\/blood-2010-12-323824","volume":"117","author":"M Arora","year":"2011","unstructured":"Arora M, Klein JP, Weisdorf DJ, Hassebroek A, Flowers ME, Cutler CS et al. Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis. Blood 2011; 117: 6714\u20136720.","journal-title":"Blood"},{"key":"BFbmt2014244_CR13","first-page":"1062","volume":"13","author":"O Ringden","year":"1985","unstructured":"Ringden O, Paulin T, Lonnqvist B, Nilsson B . Analysis of factors predisposing to chronic graft-versus-host disease. Exp Hematol 1985; 13: 1062\u20131067.","journal-title":"Exp Hematol"},{"key":"BFbmt2014244_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","volume":"9","author":"SJ Lee","year":"2003","unstructured":"Lee SJ, Vogelsang G, Flowers ME . Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 215\u2013233.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014244_CR15","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T . Scleroderma. N Engl J Med 2009; 360: 1989\u20132003.","journal-title":"N Engl J Med"},{"key":"BFbmt2014244_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/1523-1747.ep12276895","volume":"92","author":"S Gay","year":"1989","unstructured":"Gay S, Jones RE Jr, Huang GQ . Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene in scleroderma. J Invest Dermatol 1989; 92: 301\u2013303.","journal-title":"J Invest Dermatol"},{"key":"BFbmt2014244_CR17","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1182\/blood-2005-01-0062","volume":"106","author":"T Banovic","year":"2005","unstructured":"Banovic T, MacDonald KP, Morris ES, Rowe V, Kuns R, Don A et al. TGF-beta in allogeneic stem cell transplantation: friend or foe?. Blood 2005; 106: 2206\u20132214.","journal-title":"Blood"},{"key":"BFbmt2014244_CR18","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1523-1747.2003.12517.x","volume":"121","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, McCormick LL, Gilliam AC . Latency- associated peptide prevents skin fibrosis in mu- rine sclerodermatous graft-versus-host disease, a model for human scleroderma. J Invest Dermatol 2003; 121: 713\u2013719.","journal-title":"J Invest Dermatol"},{"key":"BFbmt2014244_CR19","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1200\/JCO.2001.19.16.3685","volume":"19","author":"C Cutler","year":"2001","unstructured":"Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH . Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001; 19: 3685\u20133691.","journal-title":"J Clin Oncol"},{"key":"BFbmt2014244_CR20","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/sj.leu.2402909","volume":"17","author":"M Mohty","year":"2003","unstructured":"Mohty M, Bilger K, Jourdan E, Kuentz M, Michallet M, Bourhis JH et al. Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation. Leukemia 2003; 17: 869\u2013875.","journal-title":"Leukemia"},{"key":"BFbmt2014244_CR21","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","volume":"367","author":"C Anasetti","year":"2012","unstructured":"Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med 2012; 367: 1487\u20131496.","journal-title":"N Engl J Med"},{"key":"BFbmt2014244_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1182\/blood-2009-11-256495","volume":"116","author":"GR Hill","year":"2010","unstructured":"Hill GR, Olver SD, Kuns RD, Varelias A, Raffelt NC, Don AL et al. Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma. Blood 2010; 116: 819\u2013828.","journal-title":"Blood"},{"key":"BFbmt2014244_CR23","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1200\/JCO.2010.32.7312","volume":"29","author":"B Bj\u00f6rkstrand","year":"2011","unstructured":"Bj\u00f6rkstrand B, Iacobelli S, Hegenbart U, Gruber A, Greinix H, Volin L et al. Tandem autologous\/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up. J Clin Oncol 2011; 29: 3016\u20133022.","journal-title":"J Clin Oncol"},{"key":"BFbmt2014244_CR24","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.bbmt.2005.12.034","volume":"12","author":"A Bacigalupo","year":"2006","unstructured":"Bacigalupo A, Lamparelli T, Barisione G, Bruzzi P, Guidi S, Alessandrino PE et al. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biol Blood Marrow Transplant 2006; 12: 560\u2013565.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014244_CR25","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.1182\/blood-2011-01-329821","volume":"117","author":"G Socie","year":"2011","unstructured":"Socie G, Schmoor C, Bethge WA, Ottinger HD, Stelljes M, Zander AR et al. Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius. Blood 2011; 117: 6375\u20136638.","journal-title":"Blood"},{"key":"BFbmt2014244_CR26","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1038\/leu.2010.200","volume":"24","author":"M Mohty","year":"2010","unstructured":"Mohty M, Labopin M, Bal\u00e8re ML, Socie G, Milpied N, Tabrizi R et al. Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Soci\u00e9te Fran\u00e7aise de Greffe de Moelle et de Th\u00e9rapie Cellulaire. Leukemia 2010; 24: 1867\u20131874.","journal-title":"Leukemia"},{"key":"BFbmt2014244_CR27","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1172\/JCI39395","volume":"120","author":"IK Na","year":"2010","unstructured":"Na IK, Lu SX, Yim NL, Goldberg GL, Tsai J, Rao U et al. The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease. J Clin Invest 2010; 120: 343\u2013356.","journal-title":"J Clin Invest"},{"key":"BFbmt2014244_CR28","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1182\/blood-2008-01-130146","volume":"111","author":"X Feng","year":"2008","unstructured":"Feng X, Kajigaya S, Solomou EE, Keyvanfar K, Xu X, Raghavachari N et al. Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro. Blood 2008; 111: 3675\u20133683.","journal-title":"Blood"},{"key":"BFbmt2014244_CR29","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.bbmt.2013.02.008","volume":"19","author":"DM Ponce","year":"2013","unstructured":"Ponce DM, Gonzales A, Lubin M, Castro-Malaspina H, Giralt S, Goldberg JD. et al. Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match. Biol Blood Marrow Transplant 2013; 19: 904\u2013911.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014244_CR30","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.bbmt.2013.04.006","volume":"19","author":"F Milano","year":"2013","unstructured":"Milano F, Delaney C, Storb R . Graft-versus-host-disease after double cord blood transplantation: a new look at its characteristics. Biol Blood Marrow Transplant 2013; 19: 847\u2013848.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014244_CR31","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S1083-8791(03)00216-7","volume":"9","author":"V Ratanatharathorn","year":"2003","unstructured":"Ratanatharathorn V, Ayash L, Reynolds C, Silver S, Reddy P, Becker M et al. Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biol Blood Marrow Transplant 2003; 9: 505\u2013511.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2014244_CR32","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/bmt.2008.252","volume":"42","author":"L Magro","year":"2008","unstructured":"Magro L, Catteau B, Coiteux V, Bruno B, Jouet JP, Yakoub-Agha I . Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GvHD. Bone Marrow Transplant 2008; 42: 757\u2013760.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2014244.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2014244","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2014244.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T18:14:39Z","timestamp":1648059279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2014244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["BFbmt2014244"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2014.244","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,3]]},"assertion":[{"value":"22 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}